Spyre Therapeutics, Inc. (SYRE)
85.71
+5.81
(+7.27%)
USD |
NASDAQ |
Oct 09, 16:00
85.71
0.00 (0.00%)
After-Hours: 18:26
Spyre Therapeutics Total Return Level : 79.90 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 79.90 |
| October 07, 2026 | 80.85 |
| October 06, 2026 | 80.11 |
| October 05, 2026 | 92.72 |
| October 02, 2026 | 93.19 |
| October 01, 2026 | 89.93 |
| September 30, 2026 | 89.03 |
| September 29, 2026 | 84.72 |
| September 28, 2026 | 85.79 |
| September 25, 2026 | 85.69 |
| September 24, 2026 | 87.09 |
| September 23, 2026 | 88.17 |
| September 22, 2026 | 91.97 |
| September 21, 2026 | 92.03 |
| September 18, 2026 | 90.25 |
| September 17, 2026 | 92.68 |
| September 16, 2026 | 91.17 |
| September 15, 2026 | 90.95 |
| September 14, 2026 | 90.80 |
| September 11, 2026 | 90.60 |
| September 10, 2026 | 88.71 |
| September 09, 2026 | 86.93 |
| September 08, 2026 | 90.79 |
| September 04, 2026 | 88.98 |
| September 03, 2026 | 87.25 |
| Date | Value |
|---|---|
| September 02, 2026 | 87.05 |
| September 01, 2026 | 88.50 |
| August 31, 2026 | 89.33 |
| August 28, 2026 | 90.36 |
| August 27, 2026 | 93.62 |
| August 26, 2026 | 93.60 |
| August 25, 2026 | 107.36 |
| August 24, 2026 | 106.65 |
| August 21, 2026 | 106.49 |
| August 20, 2026 | 107.79 |
| August 19, 2026 | 108.92 |
| August 18, 2026 | 107.82 |
| August 17, 2026 | 104.60 |
| August 14, 2026 | 103.63 |
| August 13, 2026 | 101.85 |
| August 12, 2026 | 104.09 |
| August 11, 2026 | 102.74 |
| August 10, 2026 | 105.33 |
| August 07, 2026 | 104.91 |
| August 06, 2026 | 103.42 |
| August 05, 2026 | 104.35 |
| August 04, 2026 | 104.94 |
| August 03, 2026 | 94.93 |
| July 31, 2026 | 98.33 |
| July 30, 2026 | 101.50 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 469.24 |
| Incyte Corp. | 112.75 |
| SELLAS Life Sciences Group, Inc. | 11.26 |
| Relay Therapeutics, Inc. | 17.41 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |